Cyclin-dependent kinase pathways as targets for cancer treatment.
作者： Geoffrey I. Shapiro
关键词:
摘要: Cyclin-dependent kinases (cdks) are critical regulators of cell cycle progression and RNA transcription. A variety of genetic and epigenetic events cause universal overactivity of the cell …
sci-hub.se 参考文章(204)
Matthew Meyerson, Greg H Enders, Chin-Lee Wu, LK Su, C Gorka, C Nelson, Ed Harlow, LH Tsai, A family of human cdc2-related protein kinases. The EMBO Journal. ,vol. 11, pp. 2909- 2917 ,(1992) , 10.1002/J.1460-2075.1992.TB05360.X
J. D. White, J. Cassidy, C. Twelves, C. Benson, S. Pacey, I. Judson, H. McGrath, F. Rose, L. Frenz, A phase I trial of the oral cyclin dependent kinase inhibitor CYC202 in patients with advanced malignancy Journal of Clinical Oncology. ,vol. 22, pp. 3042- 3042 ,(2004) , 10.1200/JCO.2004.22.14_SUPPL.3042
C. Sardet, E. N. Eaton, R. A. Weinberg, M. Picon, A. S. Lundberg, J. M. Roberts, Yan Geng, A. Gifford, Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene. ,vol. 12, pp. 1173- 1180 ,(1996)
H. J. Altermatt, N. Thatcher, J. Heighway, W. D. J. Ryder, D. C. Betticher, P. Hoban, Alternate splicing produces a novel cyclin D1 transcript. Oncogene. ,vol. 11, pp. 1005- 1011 ,(1995)
R. A. Kratzke, F. J. Kaye, Young Whan Kim, A. Coxon, G. A. Otterson, Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene. ,vol. 9, pp. 3375- 3378 ,(1994)
K. Keyomarsi, W. Toyofuku, M. P. Fox, D. Conte, Deregulation of cyclin E in breast cancer Oncogene. ,vol. 11, pp. 941- 950 ,(1995)
Andrea König, Gary K. Schwartz, Ramzi M. Mohammad, Ayad Al-Katib, Janice L. Gabrilove, The Novel Cyclin-Dependent Kinase Inhibitor Flavopiridol Downregulates Bcl-2 and Induces Growth Arrest and Apoptosis in Chronic B-Cell Leukemia Lines Blood. ,vol. 90, pp. 4307- 4312 ,(1997) , 10.1182/BLOOD.V90.11.4307
Beno��t Palancade, Olivier Bensaude, Investigating RNA polymerase II carboxyl‐terminal domain (CTD) phosphorylation FEBS Journal. ,vol. 270, pp. 3859- 3870 ,(2003) , 10.1046/J.1432-1033.2003.03794.X
Keith C. Bible, Scott H. Kaufmann, Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration. Cancer Research. ,vol. 57, pp. 3375- 3380 ,(1997)
G Reifenberger, K Ichimura, V P Collins, E E Schmidt, CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Research. ,vol. 54, pp. 6321- 6324 ,(1994)